Home LiteratureArticle Details
PMID: 2418442 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human T-cell clones used to define functional epitopes on HLA class II molecules.

Weyand CM, Goronzy J, Fathman CG

Abstract

Polyclonal reagents have been used to define HLA class II molecules in conventional serologic and cellular typing. We generated human alloreactive T-cell clones to analyze the functional fine specificities of HLA class II molecules that might be important for the phenomenon of HLA and disease association. We chose to examine HLA-Dw14, an HLA-D specificity that has been associated with juvenile rheumatoid arthritis. In this paper we have presented data that suggest that conventional cellular typing does not reflect the distribution of T-cell epitopes on major histocompatibility complex class II molecules. We describe three alloreactive T-cell clones that have defined three separate Dw14-associated T-cell epitopes. Two of these epitopes were on a DR-region molecule; the third was located on a DQ-region product. In a panel of unrelated DR4-positive donors, these three DW14-associated determinants were present in a high frequency but were not linked to each other. Within the tested panel of DR4-positive cells, all possible combinatorial arrangements of these three allodeterminants were seen. The concurrent expression of any two of the three allodeterminants was equivalent to a positive typing response for Dw14. Our finding that HLA-Dw14 is not characterized by a unique allodeterminant but by the combinatorial recognition of independently distributed T-cell interaction sites suggests that analysis of HLA and disease association may be more clearly demonstrated through the use of human T-cell clones.

MeSH Terms
Antibodies, Monoclonal/immunology Cell Line Clone Cells Epitopes/immunology HLA-DQ Antigens HLA-DR4 Antigen Haploidy Histocompatibility Antigens Class II/immunology Humans T-Lymphocytes/immunology
Chemicals
Antibodies, Monoclonal Epitopes HLA-DQ Antigens HLA-DR4 Antigen Histocompatibility Antigens Class II
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Weyand C M
Goronzy J
Fathman C G
References (21)
21 references, click to expand
  1. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.
    Hum Immunol. 1984 Aug;10(4):221-35 PMID: 6332101
  2. Functional expression of HLA-DP genes transfected into mouse fibroblasts.
    Nature. 1985 Jan 3-9;313(5997):61-4 PMID: 2578218
  3. Data reduction in HLA-D typing with the primed lymphocyte typing (PLT) technique. the normalized median response (NMR).
    Tissue Antigens. 1980 Feb;15(2):123-36 PMID: 12735313
  4. Generation of HLA-D specific primed lymphocyte typing (PLT) cells and cross-reactions of PLT-cells primed with homozygous typing cells.
    Tissue Antigens. 1980 Feb;15(2):137-51 PMID: 12735314
  5. Typing for MLC determinants by means of LD-homozygous and LD-heterozygous test cells.
    Transplant Proc. 1973 Dec;5(4):1543-9 PMID: 4130064
  6. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    J Immunol. 1976 Apr;116(4):929-35 PMID: 56405
  7. The association between genes in the major histocompatibility complex and disease susceptibility,.
    Annu Rev Med. 1977;28:425-52 PMID: 140623
  8. Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.
    Nature. 1978 Mar 23;272(5651):359-61 PMID: 76289
  9. Crossreactive mixed lymphocyte reaction determinants recognized by cloned alloreactive T cells.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5863-6 PMID: 93286
  10. Two populations of Ia-like molecules on a human B cell line.
    J Immunol. 1980 Jul;125(1):293-9 PMID: 6966655
  11. Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man.
    Proc Natl Acad Sci U S A. 1981 Jan;78(1):440-4 PMID: 6787587
  12. Multiple HLA-DR antigens: detection with monoclonal antibodies and translation in vitro.
    Proc Natl Acad Sci U S A. 1982 Apr;79(8):2658-62 PMID: 6979750
  13. Determinants not correlated with HLA-Dw, DR, or SB detected by primed lymphocyte typing.
    Hum Immunol. 1982 Jun;4(3):239-48 PMID: 6181033
  14. Five HLA-D clusters associated with HLA-DR4.
    Hum Immunol. 1982 Jun;4(3):249-58 PMID: 6181034
  15. HLA and disease 1982--a survey.
    Immunol Rev. 1983;70:193-218 PMID: 6339368
  16. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
    J Exp Med. 1983 May 1;157(5):1461-70 PMID: 6189938
  17. Dw/LD-related molecular polymorphism of DR4 beta-chains.
    J Exp Med. 1983 May 1;157(5):1687-91 PMID: 6189945
  18. Detection of a novel human class II HLA antigen.
    Nature. 1983 Jul 28-Aug 3;304(5924):358-61 PMID: 6192342
  19. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6962-6 PMID: 6417660
  20. The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules.
    J Exp Med. 1984 Feb 1;159(2):394-404 PMID: 6420500
  21. Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis.
    J Clin Invest. 1984 Jul;74(1):287-91 PMID: 6610692
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1986-02-00
Pages
762-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC322945
Subset
IM
Grants
NIAID NIH HHS · AI 18716 · United States
NIADDK NIH HHS · AM 20610 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]